Site Search
Google Search
search button
Breaking News: A Helicopter's Engine Failed While Carrying Ivanka Trump And Jared Kushner      - | -     Cavaliers Head Coach Tyronn Lue to Take Leave of Absence      - | -     White House May Not Follow Through On Executing Drug Dealers      - | -     British Prime Minister Very Concerned By Facebook Data Abuse Reports      - | -     Supreme Court Order Arizona to Gives Dreamers Drivers Licenses      - | -     Fourth Explosion In Austin Ignites Fears Of Serial Bomber      - | -     GOP Congressman Invokes 'The Deep State'
CRISPR Study Sends Biotech Stocks Tumbling
Get Business & Technology Alerts

10 Jan 2018 06:09 AM EST

On Monday, a new paper had identified a possible barrier to using the revolutionary gene-editing tool CRISPR in humans. The news sent the stocks of all three major CRISPR biotech firms tumbling in premarket trading. They declined by as much as 11.9 percent.
In recent years, CRISPR has been credited with the potential power to correct any number of devastating diseases. Researchers have used it to cure mice of deadly genetic conditions like hemophilia B, Lou Gehrig’s disease, and Huntington’s disease. In the U.S., the first human CRISPR trials are slated to begin this year.

Post Your Comment
Excellent Very Good Good Fair Poor

Recently Posted Comments
AllMediaNY AllMediaNY AllMedaiNY